If you wish to market a product containing live genetically modified organisms (GMOs) in the European Union, you must submit an application for authorisation to the competent authority of a Member State. If the product is is not intended for food, feed or medicinal products, the application for authorisation is in Finland submitted to the Board for Gene Technology.
If you are planning to submit an authorisation application, contact the Board for Gene Technology.
All EU Member States participate in the processing of the application and in practice, the approval process will take several years. If a product is granted marketing authorisation, it is always fixed-term.
If the trader is established in another EEA state and provides services in Finland on a temporary basis, they are required to have the same permits as the traders established in Finland.
The marketing authorisation for a product may be valid for a maximum of 10 years at a time.
Government Decree on Chargeable Performances under the Gene Technology Act in 2026 and 2027 (1195/2025)
Decree of the Ministry of Social Affairs and Health on the deliberate release of genetically modified organisms (1105/2019)
Government Decree on Gene Technology (928/2004)
Gene Technology Act (377/1995)